ATH 14.3% 0.3¢ alterity therapeutics limited

where is Skint?, page-18

  1. 1,640 Posts.
    lightbulb Created with Sketch. 143
    yes,scientific knowledge is great... we know so far that :

    PBT2 significantly reduces soluble amyloid [EURO]
    PBT2 shows a trend of reducing amyloid plaques, but not statistically significant over placebo[IMAGINE]
    PBT2 is twice showing trends of reduced brain atrophy
    PBT2 has twice managed to meet statistical signifcance over placebo in cognition test. [EURO, REACH2HD]
    PBT2 has been well tolerated in each trial and has almost completed a continuous 2 year period in IMAGINE.
    Animal models have shown PBT2 being effective at dealing with both amyloid and TAU, with indications it can also prevent general memory loss associated with old age.

    All that other poster presented was hyperbole on the likelihood of success, references to superseded data based on older drugs, and a few truths mixed up with misinformation and outright lies regarding their holding... i would recommend you look at the many reponses to that particular poster's comments.
    Last edited by m123456: 14/08/14
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
-0.001(14.3%)
Mkt cap ! $15.96M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $11.18K 3.279M

Buyers (Bids)

No. Vol. Price($)
38 52064257 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 126697935 22
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.